Relatively simple devices can have a huge impact on the lives of those suffering from diseases like Parkinson’s and Alzheimer’s. Watch this video to see how a teched-out…
Adi Jaffe, PhD, Co-Founder and Executive Director, Alternatives Behavioral Health, talks about considerations treatment centers should take before using the Soberlink device for their patients. According to Jaffe, the Soberlink should…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma, talks about the problems with current medications for ADHD. First class medications against ADHD include scheduled stimulants such as Ritalin, Adderall,…
Diane E. Meier, MD, FACP, Director, Center to Advance Palliative Care, Icahn School of Medicine at Mount Sinai, expounds on a new medical specialty called palliative care. Palliative…
Yaron Daniely, PhD, MBA, CEO of Alcobra Pharma talks about MDX, which, if approved, will be the first therapy of its kind for Fragile X Syndrome, the orphan disease…
Raun Kaufman, CEO & Founder, Autism Treatment Center of America, delves into how doctors can better prepare themselves to make recommendations to families about treating children with autism spectrum…
Raun Kaufman, CEO & Founder, Autism Treatment Center of America, talks about his recent book, Autism Breakthrough: The Groundbreaking Method That Has Helped Families All Over the World. The…
Raun Kaufman, CEO & Founder, Autism Treatment Center of America, describes the 4 most common misconceptions about autism. Myth #1: Autism is a behavioral disorder Reality: Autism is a social…
Raun Kaufman, CEO & Founder, Autism Treatment Center of America, was diagnosed with severe autism at a very young age. He was not capable of language or eye…
Sherry Glied, PhD, Dean, Robert F. Wagner Graduate School of Public Service, New York University, cites research from her book, Better but Not Well, which looks at the changes in…